Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update

Cited by (649)

Items 201–300 of 649

1. Galectin-4 is associated with diabetes and obesity in a heart failure population
   Anna Dieden, Petri Gudmundsson, Johan Korduner, John Molvin, Amir Zaghi, Zainu Nezami, Erasmus Bachus, Hannes Holm, Amra Jujić, Martin Magnusson · 2023 · Scientific Reports
2. Medicare formulary restrictions for glucagon-like peptide 1 receptor agonists and sodium glucose cotransporter 2 inhibitors used in type 2 diabetes mellitus: 2019-2023
   Brady Wisniewski, Eric Smith, Jasmeen Kaur, Ciara Sherling, Shravani Vanapalli, Mia E. Lussier · 2023 · Journal of Managed Care & Specialty Pharmacy
3. The WATCH-DM risk score estimates clinical outcomes in type 2 diabetic patients with heart failure with preserved ejection fraction
   Katsuomi Iwakura, Toshinari Onishi, Atsunori Okamura, Yasushi Koyama, Nobuaki Tanaka, Masato Okada, Kenshi Fujii, Masahiro Seo, Takahisa Yamada, Masamichi Yano et al. · 2024 · Scientific Reports
4. Predictive Value of NT pro BNP for New-Onset Atrial Fibrillation in Heart Failure and Preserved Ejection Fraction
   Xiao Liu, Sixu Chen, Hong Pan, Zenghui Zhang, Yue Wang, Yuan Jiang, Maoxiong Wu, Zhiteng Chen, Ayiguli Abudukeremu, Zhengyu Cao et al. · 2024 · ESC Heart Failure
5. Therapeutic Potential of Luteolin for Diabetes Mellitus and Its Complications
   Xiao-Qin Chang, Rensong Yue · 2024 · Chinese Journal of Integrative Medicine
6. MicroRNA-499 Gene Expression in Egyptian Type 2 Diabetes Mellitus Patients with and without Coronary Heart Disease.
   Heba El Sayed Oraby, Shereen Saeid Elshaer, Laila Ahmed Rashed, Noha Abdel-Rahman Eldesoky · 2021 · Azhar International Journal of Pharmaceutical and Medical Sciences/Azhar International Journal of Pharmaceutical and Medical Sciences
7. Pulmonary hypertension during exercise underlies unexplained exertional dyspnoea in patients with Type 2 diabetes
   Tin Gojevic, Lisa Van Ryckeghem, Siddharth Jogani, Ines Frederix, Elise Bakelants, Thibault Petit, Sarah Stroobants, Paul Dendale, Virginie Bito, Lieven Herbots et al. · 2022 · European Journal of Preventive Cardiology
8. Coronary artery calcification, carotid intima-media thickness and cardiac dysfunction in young adults with type 2 diabetes mellitus
   Tony Joseph, Nikunj S. Kotecha, Chetan Kumar H.B., Neeraj Jain, Aditya Kapoor, Sunil Kumar, Eesh Bhatia, Prabhakar Mishra, Saroj Kumar Sahoo · 2020 · Journal of Diabetes and its Complications
9. SGLT2 inhibitors
   Christy McDonald Lenahan, Deedra H. Harrington, Frances Stueben · 2021 · The Nurse Practitioner
10. Association between underweight and risk of heart failure in diabetes patients
    Tae Kyung Yoo, Kyungdo Han, Eun‐Jung Rhee, Won‐Young Lee · 2024 · Journal of Cachexia Sarcopenia and Muscle
11. Autophagy and mitophagy as potential therapeutic targets in diabetic heart condition: Harnessing the power of nanotheranostics
    Sagnik Nag, Oishi Mitra, Bhanu Maturi, Simran Preet Kaur, Ankita Saini, Muskan Nama, Soumik Roy, Souvik Samanta, Leena Chacko, Rohan Dutta et al. · 2024 · Asian Journal of Pharmaceutical Sciences
12. Glucagon-like Peptide-1 Receptor Agonists in the Context of Pathophysiology of Diverse Heart Failure with Preserved Ejection Fraction Phenotypes: Potential Benefits and Mechanisms of Action
    Bykova Aa, Maria Serova, M. I. Chashkina, Raisa S. Kosharnaia, Z. K. Salpagarova, Denis A. Andreev, Ilya Giverts · 2024 · Cardiac failure review
13. Association between the haemoglobin glycation index and 30-day and 365-day mortality in patients with heart failure admitted to the intensive care unit
    Ziyu Guo, Yi-Ke Li, Shuo-Yan An, Jingang Zheng · 2025 · Diabetology & Metabolic Syndrome
14. Fibro‐inflammatory recovery and type 2 diabetes remission following a low calorie diet but not exercise training: A secondary analysis of the DIASTOLIC randomised controlled trial
    Emer M. Brady, Gaurav Singh Gulsin, Evgeny M. Mirkes, Kelly S. Parke, Prathap Kanagala, Leong L. Ng, Matthew P. M. Graham-Brown, Lavanya Athithan, Joseph J. Henson, Emma L. Redman et al. · 2022 · Diabetic Medicine
15. Addressing the Continuum of Dysglycaemia and Vascular Complications in Prediabetes and Type 2 Diabetes: Need for Early and Intensive Treatment
    Nadia Ghannam, Saleh Alahmed, Raed Aldahash, Naji Aljohani, Afaf Alshammary, Ashraf Amir, Abdullah Kamal, Said Khader, Mohammed Salah, Hani Shalabi et al. · 2023 · Diabetes Metabolic Syndrome and Obesity
16. Depression is associated with heart failure in patients with type 2 diabetes mellitus
    Yanying Chen, Long Chen, Zhenhua Xing · 2023 · Frontiers in Public Health
17. Clinical usefulness of phase angle as an indicator of muscle wasting and malnutrition in inpatients with cardiovascular diseases.
    Jun Yokomachi, Taira Fukuda, Yuta Mizushima, Naohiro Nozawa, Hayato Ishizaka, Kazuhisa Matsumoto, Takahiro Kambe, Shohta Inoue, Kaori Nishikawa, Yohei Toyama et al. · 2023 · PubMed Central
18. Novel Biomarkers of Grade I Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease
    Adina Braha, Bogdan Timar, Viviana Mihaela Ivan, Monica Micloș-Balica, Larisa Dăniluc, Romulus Zorin Timar · 2024 · Journal of Clinical Medicine
19. Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease
    John W. Ostrominski, Mats Christian Højbjerg Lassen, Brian Lee Claggett, Zi Michael Miao, Silvio E. Inzucchi, Kieran F. Docherty, Akshay Suvas Desai, Pardeep S. Jhund, Lars Køber, Piotr P. Ponikowski et al. · 2024 · European Heart Journal
20. Cardiovascular Risk Reduction in Patients with Type 2 Diabetes: What Does the Cardiologist Need to Know?
    Martin Berger, Nikolaus Marx, Katharina Marx-Schütt · 2025 · European Cardiology Review
21. Cross-regulatory mechanisms linking ferroptosis, epigenetics, and circadian rhythm to mitochondrial quality control in diabetic cardiomyopathy
    Xinxin Liu, Yingqi Ma, Xue-Feng Wang, Xiao-Wen Zhang, Chen Shen, Youzhu Su, Xing Chang, Hao Zhou, Jian-Ping Liu · 2025 · Journal of Advanced Research
22. Glucose‐lowering pharmacotherapies in Chinese adults with type 2 diabetes and cardiovascular disease or chronic kidney disease. An expert consensus reported by the Chinese Diabetes Society and the Chinese Society of Endocrinology
    Tianpei Hong, Qing Su, Xiaoying Li, Zhongyan Shan, Li Chen, Yongde Peng, Liming Chen, Li Yan, Yuqian Bao, Zhaohui Lyu et al. · 2020 · Diabetes/Metabolism Research and Reviews
23. Adipose tissue–heart crosstalk as a novel target for treatment of cardiometabolic diseases
    Elia Smeir, Ulrich Kintscher, Anna Foryst‐Ludwig · 2021 · Current Opinion in Pharmacology
24. Predictive value of serum irisin for chronic heart failure in patients with type 2 diabetes mellitus
    Alexander A. Berezin, Ivan M. Fushtey, Sergii V. Pavlov, Alexander Е. Berezin · 2022 · Molecular Biomedicine
25. Prognosis of patients eligible for dapagliflozin in acute heart failure
    Sebastian Carballo, Jérôme Stirnemann, Nicolas Garin, Pauline Darbellay Farhoumand, Jacques Serratrice, David Carballo · 2020 · European Journal of Clinical Investigation
26. Purine Metabolite Signatures and Type 2 Diabetes: Innocent Bystanders or Actionable Items?
    Giulio R. Romeo, Meenu Jain · 2020 · Current Diabetes Reports
27. Social media use and mental health among older adults with multimorbidity: the role of self-care efficacy
    Zuoting Nie, Shiying Gao, Long Chen, Rumei Yang, Linda S. Edelman, Katherine Ann Sward, Yun Jiang, George Demiris · 2024 · Journal of the American Medical Informatics Association
28. Recommendations for the use of natriuretic peptides for early diagnosis of heart disease in patients with diabetes: A consensus report by SPEDM, SPC, NEDM-SPMI and APMGF
    João Sérgio Neves, Rui Baptista, Estêvão Azevedo de Pape, Manuel Rodrigues Pereira, Rita Paulos, Julian A. Santos, Cristina Gavina, João Jácome de Castro · 2024 · Revista Portuguesa de Cardiologia
29. Caries Is the Hub of a Complex Network of Chronic Diseases across the Life Decades
    Silas Alves Costa, Francisco A. Rodrigues, Alexandre Archanjo Ferraro, Gustavo G. Nascimento, Fábio Renato Manzolli Leite, Bruno Feres de Souza, Cecília Cláudia Costa Ribeiro · 2025 · Journal of Dental Research
30. Health burden in type 2 diabetes and prediabetes in The Maastricht Study
    Marja G. J. Veugen, Veronica G. Onete, Ronald M.A. Henry, Hans‐Peter Brunner‐La Rocca, Annemarie Koster, Pieter C. Dagnelie, Nicolaas C. Schaper, Simone J. S. Sep, Carla Kallen, Martin P.J. van Boxtel et al. · 2022 · Scientific Reports
31. Evaluation and Management of Patients With Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement
    Kyu‐Sun Lee, Jung Hyun Noh, Seong‐Mi Park, Kyung Mook Choi, Seok‐Min Kang, Kyu Chang Won, Hyun‐Jai Cho, Min Kyong Moon · 2023 · International Journal of Heart Failure
32. Clinician challenges to evidence‐based prescribing for heart failure and reduced ejection fraction: A qualitative evaluation
    Katy E. Trinkley, Ashley Dafoe, Daniel C. Malone, Larry A. Allen, Amy G. Huebschmann, Prateeti Khazanie, Cali Lunowa, Daniel D. Matlock, Krithika Suresh, Michael A. Rosenberg et al. · 2023 · Journal of Evaluation in Clinical Practice
33. Association between the MCP-1 -2518 A > G (rs1024611) polymorphism and susceptibility to type 2 diabetes mellitus and diabetic nephropathy: a meta-analysis
    Weiwei Chang, Liu Zhang, Li-ying Wen, Yu-jing Tao, Jiajie Xiong, Xin Tong, Yuelong Jin, Hong Su · 2023 · BMC Endocrine Disorders
34. Progenitor Cell Function and Cardiovascular Remodelling Induced by SGLT2 Inhibitors
    Theodora M. Stougiannou, Konstantinos C Christodoulou, Theocharis Koufakis, Fotios A. Mitropoulos, Dimitrios A. Mikroulis, C. David Mazer, Dimos Karangelis · 2024 · Frontiers in Bioscience-Landmark
35. Emerging Role of Natriuretic Peptides in Diabetes Care: A Brief Review of Pertinent Recent Literature
    Dipti Tiwari, Tar Choon Aw · 2024 · Diagnostics
36. Promising roles of sodium–glucose cotransporter 2 inhibitors in heart failure prevention and treatment
    Atsushi Tanaka, Koichi Node · 2020 · Diabetology International
37. Management of noncardiovascular comorbidities in patients with heart failure with reduced ejection fraction
    Stormi E. Gale, Andrew Mardis, Michael E. Plazak, Alina Kukin, Brent N. Reed · 2021 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
38. Prevalence and Prognostic Value of Heart Failure Stages: An Elderly Inpatient Based Cohort Study
    Pei-Pei Zheng, Si-Min Yao, Di Guo, L. Cui, G. Miao, W. Dong, H. Wang, Jie-Fu Yang · 2021 · Frontiers in Medicine
39. Inverse Associations Between Circulating Secreted Frizzled Related Protein 2 (sFRP2) and Cardiometabolic Risk Factors
    Mengying Cao, Hao Wang, Wenshu Li, Xueli Jiang, Xiaolin Wang, Wei Guo, Pan Gao, Yunzeng Zou · 2021 · Frontiers in Cardiovascular Medicine
40. Lifetime Risk of Heart Failure and Trends in Incidence Rates Among Individuals With Type 2 Diabetes Between 1995 and 2018
    Brian Schwartz, Colin Pierce, Ramachandran Srini Vasan, Morten Schou, Michel Ibrahim, Kevin M. Monahan, Asya Lyass, Morten Winther Malmborg, Gunnar H. Gislason, Lars Køber et al. · 2021 · Journal of the American Heart Association
41. Temporal Trends in Outcomes of ST-Elevation Myocardial Infarction Patients With Heart Failure and Diabetes
    Bassem Ali, S. Dargham, J. Al Suwaidi, H. Jneid, Charbel Abi Khalil · 2022 · Frontiers in Physiology
42. Cardiorenal Complications in Young-Onset Type 2 Diabetes Compared Between White Americans and African Americans
    Sanjoy Ketan Paul, Jonathan E. Shaw, Peter Fenici, Olga Montvida · 2022 · Diabetes Care
43. Association of rs2910164 in miR-146a with type 2 diabetes mellitus: A case–control and meta-analysis study
    Weiwei Chang, Li-ying Wen, Liu Zhang, Xin Tong, Yuelong Jin, Gui-Mei Chen · 2022 · Frontiers in Endocrinology
44. Association of tag single nucleotide polymorphisms (SNPs) at lncRNA MALAT1 with type 2 diabetes mellitus susceptibility in the Chinese Han population: A case-control study
    Weiwei Chang, Liu Zhang, Li-ying Wen, Qian Huang, Xin Tong, Yu-jing Tao, Guimei Chen · 2022 · Gene
45. A review of current key guidelines for managing high‐risk patients with diabetes and heart failure and future prospects
    Matthew M.Y. Lee, Naveed A. Sattar · 2023 · Diabetes Obesity and Metabolism
46. Effectiveness of sodium‐glucose co‐transporter‐2 inhibitors on ischaemic heart disease
    Yun Shen, Jian Zhou, Lizheng Shi, Elizabeth Nauman, Peter Todd Katzmarzyk, Eboni G. Price‐Haywood, Ronald L. Horswell, San T. Chu, Shengping Yang, Alessandra N. Bazzano et al. · 2020 · Diabetes Obesity and Metabolism
47. Stage A Heart Failure
    Pompilio Massimo Faggiano, Nicola Bernardi, Emiliano Calvi, Andrea Bonelli, Andrea Faggiano, Francesca Bursi, Marco Bosisio · 2021 · Heart Failure Clinics
48. Effect modification of the association between temperature variability and hospitalization for cardiovascular disease by comorbid diabetes mellitus: A nationwide time-stratified case-crossover analysis
    Akira Okada, Hayato Yamana, Rui Pan, Satoko Yamaguchi, Ryosuke Kumazawa, Hiroki Matsui, Kiyohide Fushimi, Yasushi Honda, Masaomi Nangaku, Toshimasa Yamauchi et al. · 2023 · Diabetes Research and Clinical Practice
49. Identification of metabolic pathways and serum biomarkers in diabetic cardiomyopathy using untargeted metabolomics
    Jialong Li, Huaming Qiu, Yanjun Wu, Su Li · 2025 · Scientific Reports
50. Pharmacologic Therapies for Type 2 Diabetes
    Bryan Kuo, Josephine H. Li · 2025 · NEJM Evidence
51. Advanced Glycation End‐Product Carboxymethyl‐Lysine and Incident Heart Failure and Atrial Fibrillation in Older Adults
    Yakubu O. Bene-Alhasan, Traci M. Bartz, Luc Djoussé, Joachim H. Ix, David S. Siscovick, John S. Gottdiener, Russell P. Tracy, Calvin H. Hirsch, Anne B. Newman, Sanjiv Jayendra Shah et al. · 2025 · Journal of the American Heart Association
52. IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes
    Moritz Hundertmark, Sarah Maria Birkhoelzer, Clara Portwood, Adrienne. G. Siu, Violet Matthews, Andrew Lewis, James T. Grist, Ferenc Emil Mózes, John Aaron Henry, Jai Patel et al. · 2025 · Circulation
53. Synchronous Health Care Delivery for the Optimization of Cardiovascular and Renal Care in Patients with Type 2 Diabetes
    Mohammad Alqahtani, Elie Ganni, Thomas A. Mavrakanas, Michael A. Tsoukas, Tricia M. Peters, Rita S. Suri, Ivan George Fantus, Antonina D. S. Pavilanis, Julian Guida, Amir Razaghizad et al. · 2022 · Current Cardiology Reports
54. Usefulness of B‐Type Natriuretic Peptide for Predicting the Risk of Stroke in Patients With Heart Failure With Preserved Ejection Fraction
    Xiao Liu, Ayiguli Abudukeremu, Peng Yu, Zhengyu Cao, Runlu Sun, Maoxiong Wu, Zhiteng Chen, Jianyong Ma, Wengen Zhu, Yangxin Chen et al. · 2022 · Journal of the American Heart Association
55. Smoking Behavior Change and the Risk of Heart Failure in Patients With Type 2 Diabetes: Nationwide Retrospective Cohort Study
    Jung Eun Yoo, Su‐Min Jeong, Kyu‐na Lee, Heesun Lee, Ji Won Yoon, Kyungdo Han, Dong Wook Shin · 2024 · JMIR Public Health and Surveillance
56. Circulating ketone bodies and mortality in heart failure: a community cohort study
    Rebecca O. Oyetoro, Katherine M. Conners, Jungnam Joo, Sarah E. Turecamo, Maureen L. Sampson, Anna T Wolska, Alan Thomas Remaley, James D. Otvos, Margery A. Connelly, Nicholas Bradley Larson et al. · 2024 · Frontiers in Cardiovascular Medicine
57. Increased Interleukin-6 is Associated with Higher Risk of Heart Failure in People with Type 2 Diabetes
    Sharon Remmelzwaal, Stanley M.H. Yeung, Marieke Tabo Blom, Martin H. de Borst, Petra J. M. Elders, Joline W. J. Beulens · 2024 · ESC Heart Failure
58. Association between the triglyceride glucose index and length of hospital stay in patients with heart failure and type 2 diabetes in the intensive care unit: a retrospective cohort study
    Kai Zhang, Yu Han, Gao Yu, Fang Ming Gu, Tianyi Cai, Zhao Xuan Gu, Zhao Jia Yu, Min Gao, Ya Fang Gao, Rui Min Hu et al. · 2024 · Frontiers in Endocrinology
59. Hypoglycemic Drugs in Patients with Diabetes Mellitus and Heart Failure: A Narrative Review
    Anastasia Nikolaidou, Ioannis Ventoulis, Georgios Karakoulidis, Vasileios Anastasiou, Stylianos Daios, Spyridon-Filippos Papadopoulos, Matthaios Didagelos, John Parissis, Theodoros D. Karamitsos, Kalliopi Kotsa et al. · 2024 · Medicina
60. The modern paradigm of pathophysiology, prevention and treatment of heart failure in type 2 diabetes mellitus
    Ж. Д. Кобалава, Vadim Medovchshikov, Nurlan Yeshniyazov, Э. Р. Хасанова · 2019 · Russian Journal of Cardiology
61. Vitamin D Status, Fiber Intake, and Type 2 Diabetes in U.S. Adults
    Jung Hyun Kwak, Yoon‐Hyeong Choi, Jean Kyung Paik · 2020 · Journal of Medicinal Food
62. Recomendaciones para el manejo del riesgo cardiorrenal en el paciente con diabetes mellitus tipo 2
    Gilberto A. Castillo, Gustavo Aroca, Jannes Buelvas, Andrés F. Buitrago, Virgil Carballo-Zárate, Juan Mauricio Cárdenas, Efraín A. Gómez, Karen Fériz, John Mauricio Lopera, Enrique Melgarejo R. et al. · 2020 · Revista Colombiana de Cardiología
63. Network Pharmacology‐Based Strategy Reveals the Effects of Hedysarum multijugum Maxim.‐Radix Salviae Compound on Oxidative Capacity and Cardiomyocyte Apoptosis in Rats with Diabetic Cardiomyopathy
    Shiying Zhang, Zhiying Yuan, Huaying Wu, Weiqing Li, Liang Li, Huiyong Huang · 2020 · BioMed Research International
64. Long‐Term Mortality Associated With Use of Carvedilol Versus Metoprolol in Heart Failure Patients With and Without Type 2 Diabetes: A Danish Nationwide Cohort Study
    Brian Schwartz, Colin Pierce, Christian Madelaire, Morten Schou, Søren Lund Kristensen, Gunnar Gislason, Lars Køber, Christian Tobias Torp-Pedersen, Charlotte Andersson · 2021 · Journal of the American Heart Association
65. Probable Dapagliflozin-Associated Acute Pancreatitis
    Ashlee D. Barrett, Mason A. Pitts, Elizabeth M. Myers, Jeremy L. Johnson · 2021 · Diabetes Spectrum
66. Reversible Thiol Oxidation Increases Mitochondrial Electron Transport Complex Enzyme Activity but Not Respiration in Cardiomyocytes from Patients with End-Stage Heart Failure
    Ravi A. Kumar, Trace Thome, Omar M. Sharaf, TERENCE EDWARD RYAN, George J. Arnaoutakis, Eric I-Hun Jeng, Leonardo F. Ferreira · 2022 · Cells
67. Glycemic control and its associated factors among diabetic heart failure outpatients at two major hospitals in Jordan
    Anan S. Jarab, Walid A. Al-Qerem, Hanan Hamam, Shrouq Abu Heshmeh, Sayer I. Al-Azzam, Tareq Lewis Mukattash, Eman A. Alefishat · 2023 · PLoS ONE
68. Blood Pressure and Glycemic Control Among Ambulatory US Adults With Heart Failure: National Health and Nutrition Examination Survey 2001 to 2018
    Leah B. Rethy, Thanh-Huyen T. Vu, Nilay S. Shah, Mercedes R. Carnethon, Tara Lagu, Mark D. Huffman, Clyde W. Yancy, Donald M. Lloyd‐Jones, Sadiya S. Khan · 2022 · Circulation Heart Failure
69. Important Considerations for the Treatment of Patients with Diabetes Mellitus and Heart Failure from a Diabetologist’s Perspective: Lessons Learned from Cardiovascular Outcome Trials
    Chrysi C. Koliaki, Nicholas L. Katsilambros · 2019 · International Journal of Environmental Research and Public Health
70. The effect of management of older patients with heart failure by general physicians on mortality and hospitalization rates: a retrospective cohort study
    Kasumi Nishikawa, Ryuichi Ohta, Chiaki Sano · 2024 · BMC Family Practice
71. Gait speed after mild stroke/transient ischemic attack was associated with long‐term adverse outcomes: A cohort study
    Ning Li, Jia Zhang, Yang Du, Jing Li, Anxin Wang, Xingquan Zhao · 2024 · Annals of Clinical and Translational Neurology
72. Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy—Challenges and Prospectives
    Elina Khattab, Michaelia Kyriakou, Elena Leonidou, Stefanos Sokratous, Angeliki Mouzarou, Michael M. Myrianthefs, Nikolaos P. E. Kadoglou · 2025 · Pharmaceuticals
73. The impact of the lactate-to-albumin ratio on long-term mortality risk in patients with severe heart failure and type 2 diabetes
    Yanyan Dong, Xiaoyu Shi, Chenghao Wang, Yinqin Hu, Junxiong Li, Hong L Luo, Maoping Zhu, Fan Hu, Quangen Chu · 2025 · BMC Cardiovascular Disorders
74. Corneal confocal microscopy identifies early and definite diabetic cardiac autonomic neuropathy
    Shazli Azmi, Maryam Ferdousi, Alise Kalteniece, Ioannis Nikolaos Petropoulos, Uazman Alam, Georgios Ponirakis, Omar Asghar, Andrew G. Marshall, Andrew J.M. Boulton, Nathan Efron et al. · 2025 · Diabetes Research and Clinical Practice
75. Exploring the role of glucagon-like peptide-1 receptor agonists in critical illness: mechanisms, benefits, and clinical implications
    Vidit G. Jogani, Osman Mohamed Elfadil, Jithinraj Edakkanambeth Varayil, Manpreet S. Mundi · 2025 · Current Opinion in Critical Care
76. Inflammatory storm and metabolic disorders: unraveling heterogeneity in mortality risk for comorbid diabetes mellitus and heart failure via the C-reactive protein-triglyceride-glucose index
    Na Zhang, Lin Xie, Shuhua Zhang, Qun Wang, Hengcheng Lu, Zhiyu Xiong, Guobo Xie, Guotai Sheng, Hongyi Yang, Shiming He et al. · 2025 · Frontiers in Endocrinology
77. GLP‐1 Receptor Agonists for the Prevention of New‐Onset Heart Failure: A Systematic Review and Meta‐Analysis of Placebo‐Controlled Randomized Clinical Trials
    João Sérgio Neves, Carolina B. Lobato, Ana Rita Leite, Catarina Vale, Francisco Vasques‐Nóvoa, Francisca A. Saraiva, Adelino Ferreira Leite-Moreira, Jens Juul Holst, João Pedro Ferreira · 2025 · Obesity Reviews
78. 4-HNE-induced cellular dysfunction from lipid peroxidation: a potential therapeutic target in diabetic cardiomyopathy
    Nan Jiang, Yanchun Ma, Huijun Chen, Chengjia Li · 2026 · Frontiers in Cell and Developmental Biology
79. Association between neutrophil-to-lymphocyte ratio and left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus
    Xueyang Yang, Yinze Shi, Huan Zhang, Liying Huang, Jiaoyue Zhang, Jie Min, Lulu Chen · 2025 · Frontiers in Endocrinology
80. Advances in incretin therapies for targeting cardiovascular disease in diabetes
    Timothy D. Roberts, Dana S. Hutchinson, Denise L. Wootten, Miles J. De Blasio, Rebecca Helen Ritchie · 2025 · Journal of Molecular and Cellular Cardiology
81. When belongingness backfires: experienced discrimination predicts increased cardiometabolic risk among college students high in social belonging
    Maryam Hussain, Angela E. Johnson, Jacqueline Hua, Bianca Marie Hinojosa, Matthew Jason Zawadzki, Jennifer L. Howell · 2021 · Journal of Behavioral Medicine
82. A nationwide cohort investigation on pay-for-performance and major adverse limb events in patients with diabetes
    Cheng‐Wei Lu, Yi-Fang Wu, Tien‐Hsing Chen, Chang‐Min Chung, Chun‐Liang Lin, Yu‐Sheng Lin, Mei‐Yen Chen, Yao‐Hsu Yang, Ming‐Shyan Lin · 2021 · Preventive Medicine
83. Interrelationship between micronutrients and cardiovascular structure and function in type 2 diabetes
    Grace W. M. Walters, Emma L. Redman, Gaurav Singh Gulsin, Joseph J. Henson, Stavroula Argyridou, Thomas E. Yates, Melanie Jane Davies, Kelly S. Parke, Gerry Patrick McCann, Emer M. Brady · 2021 · Journal of Nutritional Science
84. Analysis of Communal Molecular Mechanism and Potential Therapeutic Targets in Heart Failure and Type 2 Diabetes Mellitus
    Zuoxiang Wang, Yiyu Gu, Yunjuan Sun, Yinan Xu, Mingyang Zhang, Tingbo Jiang · 2021 · International Journal of General Medicine
85. Empagliflozin for Patients with Heart Failure and Type 2 Diabetes Mellitus: Clinical Evidence in Comparison with Other Sodium-Glucose Co-transporter-2 Inhibitors and Potential Mechanism
    Bo Liang, Rui Li, Peng Zhang, Ning Gu · 2022 · Journal of Cardiovascular Translational Research
86. Relation of genetic polymorphisms in microRNAs with diastolic and systolic function in type 2 diabetes mellitus
    Dandan Sun, Zaihan Zhu, Yanfen Zhang, Ruocen Bai, Fang Zhu, Zhongyan Shan, Chunyan Ma, Jun Yang · 2022 · Nutrition Metabolism and Cardiovascular Diseases
87. Disparities in Postdischarge Ambulatory Care Follow‐Up Among Medicaid Beneficiaries With Diabetes, Hospitalized for Heart Failure
    Yulia A. Khodneva, Emily B. Levitan, Pankaj Kumar Arora, Caroline A. Presley, Suzanne Oparil, Andrea Cherrington · 2023 · Journal of the American Heart Association
88. Control for multiple risk factors and incident heart failure and mortality in patients with diabetes mellitus: Insights from the Kailuan cohort study
    Wenqi Xu, Xinmu Li, Gary Tse, Jeffrey Shi Kai Chan, Shouling Wu, Tong Liu · 2024 · Current Problems in Cardiology
89. Update on the Impact of Comorbidities on the Efficacy and Safety of Heart Failure Medications
    Christine Chow, Robert John Mentz, Stephen John Greene · 2021 · Current Heart Failure Reports
90. Dysglycemia and incident heart failure among blacks: The jackson heart study
    Justin Basile Echouffo-Tcheugui, Stanford E. Mwasongwe, Solomon K. Musani, Michael E. Hall, Adolfo Correa, Adrian F. Hernandez, Sherita Hill Golden, Robert John Mentz, Alain Gerald Bertoni · 2021 · American Heart Journal
91. Beyond the myocardium? SGLT2 inhibitors target peripheral components of reduced oxygen flux in the diabetic patient with heart failure with preserved ejection fraction
    Mouhamed Nashawi, Omar Sheikh, Ayman Battisha, Mahnoor Mir, ROBERT J. CHILTON · 2020 · Heart Failure Reviews
92. Impaired autophagy flux contributes to enhanced ischemia reperfusion injury in the diabetic heart
    Jialing Tang, Nanyoung Yoon, Keith Dadson, Hye Kyoung Sung, Yubin Lei, Thanh Q. Dang, Wing Yan Chung, Saher Ahmed, Ali A. Abdul Sater, Jun Wu et al. · 2024 · Autophagy Reports
93. Epidemiology of Atrial Fibrillation in Heart Failure
    Nikhila Chelikam, Aashish Katapadi, Naga Venkata K. Pothineni, Douglas J Darden, Rajesh Kabra, Rakesh Gopinathannair, Dhanunjaya Lakkireddy · 2024 · Cardiac Electrophysiology Clinics
94. Pharmacology and Therapeutic Potential of Finerenone: A Novel Third-Generation Nonsteroidal Mineralocorticoid Receptor Antagonist
    Mahmoud Mohammed Ramadan, Shaha Alajmi, Jude Aldouseri, Manar Alajmi, E. Tello, Abdul-Majeed O Mahdi, Ahmad J Aladwani, Abdulrahman Emad AlAyyaf, Ousama Mahdi, Mohammed Elmahal · 2025 · Cureus
95. Icariin attenuates diabetic cardiomyopathy by activating Nrf2-dependent antioxidant and mitochondrial pathways: Integrative evidence from network pharmacology and experimental validation
    Zhongzheng Zhang, Haowen Zhuang, Chongkai Fang, Yongheng Lai, Sijia Zhang, Mengyuan Wang, Jinhong Chen, Qing Liu, Junyan Wang, Silin Liu · 2025 · Journal of Ethnopharmacology
96. Identification and correction for collider bias in a genome-wide association study of diabetes-related heart failure.
    Yan V. Sun, Chang Liu, Qin Hui, Jin J Zhou, J. Gaziano, Peter W. F. Wilson, Jacob Joseph, L. S. Phillips · 2024 · American Journal of Human Genetics
97. Exercise Reduces Glucose Intolerance, Cardiac Inflammation and Adipose Tissue Dysfunction in Psammomys obesus Exposed to Short Photoperiod and High Energy Diet
    Joanne T. M. Tan, Kiara J. Price, Sarah-Rose Fanshaw, Carmel Bilu, Quang Tuan Pham, Anthony Pham, Lauren Sandeman, Victoria A. Nankivell, Emma L. Solly, Noga Kronfeld‐Schor et al. · 2024 · International Journal of Molecular Sciences
98. Sex Differences in Diabetic Cardiomyopathy and Treatment Response to AT-001
    Vanessa L. Blumer, James L. Januzzi, Yuxi Liu, Javed Butler, Justin Adrian Ezekowitz, Riccardo Perfetti, Julio Rosenstock, Stefano Del Prato, W.H. Wilson Tang, Alessia Urbinati et al. · 2025 · JACC Heart Failure
99. HEART REMODELING, TREATMENT OF MYOCARDIAL INFARCTION WITH DIABETES MELLITUS 2ND TYPE AND HEART FAILURE
    Maksim Potyazhenko, Nadia O. Lyulka, Ю А Остапчук · 2020 · Wiadomości Lekarskie
100. Optimizing sodium-glucose co-transporter 2 inhibitor use in patients with heart failure with reduced ejection fraction: A collaborative clinical practice statement
     Bruce A. Warden, Johannes Steiner, Albert Camacho, Khoa Anh Nguyen, Jonathan Q. Purnell, Paul Barton Duell, Courtney Craigan, Diane Osborn, Sergio Fazio · 2021 · American Journal of Preventive Cardiology